Type your tag names separated by a space and hit enter

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment with second-generation antidepressive agents

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment with second-generation antidepressive agents is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please sign in or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception

"Snowball fingers" - Image

Botulinum toxin for the treatment of strabismus: Cochrane systematic review

ACC/AHA: Fewer patients require prophylaxis for endocarditis

Citation

"Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment With Second-generation Antidepressive Agents." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455055/all/Clinical_response_and_risk_for_reported_suicidal_ideation_and_suicide_attempts_in_pediatric_antidepressant_treatment_with_second_generation_antidepressive_agents.

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment with second-generation antidepressive agents. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455055/all/Clinical_response_and_risk_for_reported_suicidal_ideation_and_suicide_attempts_in_pediatric_antidepressant_treatment_with_second_generation_antidepressive_agents. Accessed February 16, 2019.

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment with second-generation antidepressive agents. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/455055/all/Clinical_response_and_risk_for_reported_suicidal_ideation_and_suicide_attempts_in_pediatric_antidepressant_treatment_with_second_generation_antidepressive_agents

Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment With Second-generation Antidepressive Agents [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 February 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455055/all/Clinical_response_and_risk_for_reported_suicidal_ideation_and_suicide_attempts_in_pediatric_antidepressant_treatment_with_second_generation_antidepressive_agents

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case

TY - ELEC T1 - Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment with second-generation antidepressive agents ID - 455055 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455055/all/Clinical_response_and_risk_for_reported_suicidal_ideation_and_suicide_attempts_in_pediatric_antidepressant_treatment_with_second_generation_antidepressive_agents PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -